Mass human exposure to rabies in New Hampshire: Exposures, treatment, and cost

American Journal of Public Health

Volumn 86, Issue 8 I, 1996, Pages 1149-1151

  Noah, Donald L ^a   Smith, M Geoffrey ^b   Gotthardt, Joan C ^a   Krebs, John W ^a   Green, Douglas ^a   Childs, James E ^a,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Bureau of Disease Control   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ADOLESCENT; ADULT; ARTICLE; BITE; CAT; CHILD; DRUG COST; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; POPULATION EXPOSURE; PRACTICE GUIDELINE; RABIES; SKIN ABRASION; UNITED STATES;

EID: 0029760926     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/ajph.86.8_pt_1.1149     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Rabies prevention - United States, 1991. MMWR. 1991;40:1-19.
2. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington DC: Public Health Service; 1990:122. DHHS publication PHS 91-50213.
3. Anderson LJ, Winkler WG. The Center for Disease Control's experience with a human diploid cell rabies vaccine. Proceedings of the 11th ICC and the 19th ICAAC. American Society of Microbiology, Boston, Mass, 1980:1357-1359.
4. Anderson LJ, Sikes RK, Langkop CW, et al. Postexposure trial of a human diploid cell strain rabies vaccine. J Infect Dis. 1980;142:133-138.
5. Anderson LJ, Winkler WG, Hafkin B, Keenlyside RA, D'Angelo LJ, Deitch MW. Clinical experience with a human diploid cell rabies vaccine. JAMA. 1980;244:781-784.
6. Fishbein DB, Dreesen DW, Holmes DF, et al. Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster preexposure immunizations. Vaccine. 1989;7:437-742.
7. Bernard KW, Smith PW, Kader FJ, Moran MJ. Neuroparalytic illness and human diploid cell rabies vaccine. JAMA. 1982;248:3136-3138.
8. Boe E, Nylan H, Guillain-Barré syndrome after vaccination with human diploid cell rabies vaccine. Scand J Infect Dis. 1980;12:231-232.
9. Knittel T, Ramadori G, Mayet WJ, Lohr H, Meyer zum Buschenfelde KH. Guillain-Barré syndrome and human diploid cell rabies vaccine. Lancet. 1989;1:1334-1335.
10. Centers for Disease Control and Prevention. The cost of one rabid dog - California. MMWR. 1981;30:527.
11. Centers for Disease Control and Prevention. Mass treatment of humans exposed to rabies - New Hampshire. MMWR. 1995;44:484-486.
12. Afshar A. A review of non-bite transmission of rabies virus infection. Br Vet J. 1979;135:142-148.
13. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barré syndrome following vaccination in the national influenza immunization program, United States, 1976-1977. Am J Epidemiol. 1979;110:105-123.
14. Schonberger LB, Hurwitz ES, Katona P, Holman RC, Bregman DJ. Guillain-Barré syndrome and associations with influenza vaccination. Ann Neurol. 1981;9(suppl): 31-38.